Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS DEFICIT

v3.22.2.2
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS DEFICIT - USD ($)
Class B common stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance beginning of period at Dec. 31, 2020 $ 863 $ 24,137 $ (1,000) $ 24,000
Balance beginning of period (in shares) at Dec. 31, 2020 8,625,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Accretion for Class A ordinary shares to redemption amount   (24,137) (30,090,469) (30,114,606)
Net income     432,609 432,609
Balance end of period at Mar. 31, 2021 $ 863   (29,658,860) (29,657,997)
Balance end of period (in shares) at Mar. 31, 2021 8,625,000      
Balance beginning of period at Dec. 31, 2020 $ 863 $ 24,137 (1,000) 24,000
Balance beginning of period (in shares) at Dec. 31, 2020 8,625,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income       5,315,873
Change in value of Class A common stock subject to possible redemption       (30,103,030)
Balance end of period at Sep. 30, 2021 $ 863   (24,786,140) (24,785,277)
Balance end of period (in shares) at Sep. 30, 2021 8,625,000      
Balance beginning of period at Mar. 31, 2021 $ 863   (29,658,860) (29,657,997)
Balance beginning of period (in shares) at Mar. 31, 2021 8,625,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Accretion for Class A ordinary shares to redemption amount     (5,243) (5,243)
Net income     (293,174) (293,174)
Balance end of period at Jun. 30, 2021 $ 863   (29,957,277) (29,956,414)
Balance end of period (in shares) at Jun. 30, 2021 8,625,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Accretion for Class A ordinary shares to redemption amount     (5,301) (5,301)
Net income     5,176,438 5,176,438
Balance end of period at Sep. 30, 2021 $ 863   (24,786,140) (24,785,277)
Balance end of period (in shares) at Sep. 30, 2021 8,625,000      
Balance beginning of period at Dec. 31, 2021 $ 863   (23,293,331) (23,292,468)
Balance beginning of period (in shares) at Dec. 31, 2021 8,625,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income     4,654,723 4,654,723
Change in value of Class A common stock subject to possible redemption     (28,158) (28,158)
Balance end of period at Mar. 31, 2022 $ 863   (18,666,766) (18,665,903)
Balance end of period (in shares) at Mar. 31, 2022 8,625,000      
Balance beginning of period at Dec. 31, 2021 $ 863   (23,293,331) (23,292,468)
Balance beginning of period (in shares) at Dec. 31, 2021 8,625,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income       11,015,318
Change in value of Class A common stock subject to possible redemption       (2,078,248)
Balance end of period at Sep. 30, 2022 $ 863   (14,356,261) (14,355,398)
Balance end of period (in shares) at Sep. 30, 2022 8,625,000      
Balance beginning of period at Mar. 31, 2022 $ 863   (18,666,766) (18,665,903)
Balance beginning of period (in shares) at Mar. 31, 2022 8,625,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income     3,842,842 3,842,842
Change in value of Class A common stock subject to possible redemption     (490,021) (490,021)
Balance end of period at Jun. 30, 2022 $ 863   (15,313,945) (15,313,082)
Balance end of period (in shares) at Jun. 30, 2022 8,625,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income     2,517,753 2,517,753
Change in value of Class A common stock subject to possible redemption     (1,560,069) (1,560,069)
Balance end of period at Sep. 30, 2022 $ 863   $ (14,356,261) $ (14,355,398)
Balance end of period (in shares) at Sep. 30, 2022 8,625,000